Ocular Therapeutix, Inc. has granted inducement equity awards to five newly hired non-executive employees, effective February 2, 2026. The awards include non-statutory stock options to purchase up to a total of 13,850 shares of common stock at an exercise price of $9.15 per share, and restricted stock units representing a total of 4,600 shares. The stock options have a ten-year term and vest over four years, with 25% vesting after one year and the remainder vesting monthly over the following three years. The restricted stock units vest in equal annual installments over three years, starting February 2, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9650553) on February 06, 2026, and is solely responsible for the information contained therein.